Pre-Clinical Investigation of a New PD-L1 B-Cell Epitope Peptide Vaccine PDL1-Vaxx

Explore a groundbreaking 11-minute webinar presented by Jay Overholser, Lab Manager in Professor Pravin Kaumaya's lab at The Ohio State University Wexner Medical Center. Delve into the pre-clinical investigation of a novel PD-L1 B cell epitope peptide vaccine, PDL1-Vaxx, and its potential implications in cancer immunotherapy. Gain insights from Overholser's expertise in the Department of Obstetrics and Gynecology as he discusses the development and preliminary findings of this innovative vaccine approach. Learn about the latest advancements in cancer research and how this new peptide vaccine could potentially enhance immune responses against tumors.